Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse

Journal of Clinical Investigation

Volumn 102, Issue 9, 1998, Pages 1749-1757

  Oude Elferink, Ronald P J ^a   Ottenhoff, Roel ^a   Van Marle, Jan ^a   Frijters, Charles M G ^a   Smith, Alexander J ^a,b   Groen, Albert K ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Bile; Cholestasis; Hypercholesterolemia; Lipoproteins; Multidrug resistance; P glycoprotein

Indexed keywords

BILIRUBIN; CHOLESTEROL; GLYCOPROTEIN P; LIPOPROTEIN X; MULTIDRUG RESISTANCE PROTEIN; PHOSPHATIDYLCHOLINE;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE; BILE DUCT LIGATION; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ELECTRON MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; HYPERCHOLESTEROLEMIA; LIPID VESICLE; LIPOPROTEIN SYNTHESIS; MOUSE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL;

EID: 0032212897     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci3597     Document Type: Article

References (33)

1. Seidel, D., P. Alaupovic, and R.H. Furman. 1969. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J. Clin. Invest. 48:1211-1223.
2. Kunkel, H.G., and E.H. Ahrens. 1949. The relationship between serum lipids and the electrophoretic pattern, with particular reference to patients with primary biliary cirrhosis. J. Clin. Invest. 28:1575-1579.
3. Felker, T.E., R.L. Hamilton, and R.J. Havel. 1978. Secretion of lipoprotein-X by perfused livers of rats with cholestasis. Proc. Natl. Acad. Sci. USA. 75: 3459-3463.
4. O, K., and J. Frohlich. 1995. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-1 in cholesterol esterification in lipoprotein X in vitro. J. Lipid Res. 36:2344-2354.
5. Manzato, E., R. Fellin, G. Baggio, S. Walch, W. Neubeck, and D. Seidel. 1976. Formation of LpX. Its relationship to bile compounds. J. Clin. Invest. 57: 1248-1260.
6. Hamilton, R.L., R.J. Havel, J.P. Kane, A.E. Blaurock, and T. Sata. 1971. Cholestasis: lamellar structure of the abnormal human serum lipoprotein. Science. 172:475-478.
7. Laggner, P., O. Glatter, K. Muller, O. Kratky, G. Kostner, and A. Holasek. 1977. The lipid bilayer structure of the abnormal human plasma lipoprotein X. An X-ray small-angle-scattering study. Eur. J. Biochem. 77:165-171.
8. Picard, J., D. Veissiere, F. Voyer, and G. Bereziat. 1971. Composition en acides gras des phospholipides dans les lipoprotéines sériques anormales de la cholostase. Clin. Chim. Acta. 36:247-250.
9. Sabesin, S.M. 1982. Cholestatic lipoproteins - their pathogenesis and significance. Gastroenterology. 83:704-709.
10. Guerin, M., P.J. Dolphin, and M.J. Chapman. 1993. Familial lecithin: cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval. Atherosclerosis. 104:195-212.
11. Tashiro, T., Y. Mashima, H. Yamamori, K. Horibe, M. Nishizawa, M. Sanada, and K. Okui. 1991. Increased lipoprotein X causes hyperlipidemia during intravenous administration of 10% fat emulsion in man. J. Parenter. Enter. Nutr. 15:546-550.
12. Smit, J.J.M., A.H. Schinkel. R.P.J. Oude Elferink, A.K. Groen, E. Wagenaar, L. Van Deemter, C.A.A.M. Mol, R. Ottenhoff, N.M.T. Van der Lugt, M. A. van Roon, et al. 1993. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75:451-462.
13. Oude Elferink, R.P.J., G.N J. Tytgat, and A.K. Groen. 1997. The role of mdr2 P-glycoprotein in hepatobiliary lipid transport. FASEB (Fed. Am. Soc. Exp. Biol) J. 11:19-28.
14. Oude Elferink, R.P.J., R. Ottenhoff. M. van Wijland, J.J.M. Smit, A.M. Schinkel, and A.K. Groen. 1995. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J. Clin. Invest. 95:31-38.
15. Crawford, J.M., G. Möckel, A.R. Crawford, S.J. Hagen, V.C. Hatch, S. Barnes, J.J. Godleski, and M.C. Carey. 1995. Imaging biliary lipid secretion in the rat: ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane. J. Lipid Res. 36:2147-2163.
16. Crawford, A.R., A.J. Smith, V.C. Hatch, R.P.J. Oude Elferink, P. Borst, and J.M. Crawford. 1997. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy. J. Clin. Invest. 100:2562-2567.
17. Smith, A.J., J.M.L. de Vree, R. Ottenhoff, R.P.J. Oude Elferink, A.H. Schinkel, and P. Borst. 1998. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2(-/-) mice. Hepatology. 28:530-536.
18. Chapman, M.J., S. Goldstein, D. Lagrange, and P.M. Laplaud. 1981. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid Res. 22:339-358.
19. Huang, H.S., J.C.W. Kuan, and G.G. Guibault, 1975. Fluorimetric enzymatic determination of total cholesterol in serurn. Clin. Chem. 21:1605-1608.
20. Voshol, P.J., R. Havinga, H. Wolters, R. Ottenhoff, H.M.G. Princen, R.P.J. Oude Elferink, A.K. Groen, and F. Kuipers. 1998. Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoprotein deficient mice. Gastroenterology. 114:1024-1034.
21. Chisholm, J.W., and P.J. Dolphin. 1996. Abnormal lipoproteins in the ANIT-treated rat: a transient and reversible animal model of intrahepatic cholestasis. J. Lipid Res. 37:1086-1098.
22. Juranka, P.F., R.L. Zastawny, and V. Ling. 1989. P-glycoprotein: multidrug resistance and a superfamily of membrane-associated transport proteins. FASEB (Fed. Am. Soc. Exp. Biol.) J. 3:2583-2592.
23. Smit, J.M.M., A.H. Schinkel, C.A.A.M. Mol, D. Majoor, W.J. Mooi, A.P.M. Jongsma, CR. Lineke, and P. Borst. 1994. Tissue distribution of the human MDR3 P-glycoprotein. Lab. Invest. 71:638-649.
24. Barr, V.A., and A.L. Hubbard. 1993. Newly synthesized hepatocyte plasma membrane proteins are transported in transcytotic vesicles in the bile duct ligated rat. Gasiroenterology. 105:554-571.
25. Stieger, B., P.J. Meier, and L. Landmann. 1994. Effect of obstructive cholestasis on membrane traffic and domain-specific expression of plasma membrane proteins in rat liver parenchymal cells. Hepatology. 20:201-212.
26. Accatino, L., M. Pizarro, N. Sous, C.S. Koenig, V. Vollrath, and J. Chianale. 1996. Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat. J. Hepatol. 25:349-361.
27. Walli, A.K., and D. Seidel. 1984. Role of lipoprotein X in the pathogenesis of cholestatic hypercholesterolemia. J. Clin. Invest. 74:867-879.
28. Ahrens, E.H., and H.G. Kunkel. 1949. The relationship between serum lipids and skin xanthomata in eighteen patients with primary biliary cirrhosis. J. Clin. Invest. 28:1565-1574.
29. Edwards, C.M., M.P. Otal, and P.W. Stacpoole. 1993. Lipoprotein X fails to inhibit hydroxymethylglutaryl coenzyme A reductase in HepG2 cells. Metabolism. 42:807-813.
30. Liersch, M., G. Baggio, C.C. Heuck, and D. Seidel. 1977. Effect of lipoprotein X on hepatic cholesterol synthesis. Atherosclerosis. 26:505-514.
31. Kattermann, R., and W. Creutzfeldt. 1970. The effect of experimental cholestasis on the negative feedback regulation of cholesterol synthesis in rat liver. Scand. J. Gastroenierol. 5:337-342.
32. Harry, D.S., M. Dini. and N. McIntyre. 1973. Effect of cholesterol feeding and biliary obstruction on hepatic cholesterol biosynthesis in the rat. Biochim. Biophys. Ada. 296:209-220.
33. McIntyre, N., D.S. Harry, and A.J.G. Pearson. 1975. The hypercholes-terolemia of obstructive jaundice. Gut. 16:379-391.